Detalhe da pesquisa
1.
Glycolipid-peptide conjugate vaccines elicit CD8+ T-cell responses and prevent breast cancer metastasis.
Clin Transl Immunology;
11(7): e1401, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35795321
2.
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia.
Leukemia;
34(6): 1524-1539, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31848452
3.
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-ß and epidermal growth factor receptor.
J Drug Target;
27(8): 903-916, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30615483
4.
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.
Clin Cancer Res;
25(14): 4493-4503, 2019 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31015346
5.
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.
Cancer Cell;
36(6): 660-673.e11, 2019 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31821784
6.
Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer.
J Drug Target;
24(5): 441-9, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26373825
7.
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.
Int J Nanomedicine;
11: 179-200, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26811677
8.
A Response to Daking and Dodds.
Health Inf Manag;
36(2): 23-25, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28758480
9.
Australian Mortality Coding: History, Benefits and Future Directions.
Health Inf Manag;
35(3): 41-45, 2006 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28758448